From the right: Musk Could Save AI from Lefty Bias The left’s “anger toward the disruptive billionaire, Tesla founder and now Donald Trump bestie,” Elon Musk, will only “get worse,” cheers Liz Peek at The Hill . “Musk’s growing investment in AI” can “likely prevent progressives from establishing a monopoly on revisionist history, in which the U.S. can be portrayed as a nation born in racism and sustained by exploitation and patriarchy.” With chatbots like ChatGPT showing a lefty bias, “Musk is busily creating his own artificial intelligence firm,” xAI. “Just as X became a loathed rival to Meta and TikTok as a source of information, so will xAI present users with a distinctly different view of the world.” “Musk’s emergence as a player in the AI world is reassuring, in that balance is important.” Elex analyst: Democrats’ Woes Not Just Messaging “Democrats and their media allies acknowledged mistakes were made” in the 2024 campaign, but claim “their real problem was a failure to communicate,” observes Real Clear Politics’ J. Peder Zane . No: “Polls show a large majority of Americans have lost faith in their ability to govern effectively,” after “Democrat-run states and major cities have distinguished themselves not only for their poorly run schools, high crime, and massive debts, but also their corruption.” Moreover, “their embrace of the woke agenda showed that the party was not just wrong about certain issues, but in the grips of an unhinged ideology.” Indeed, Trump won “because many Americans remembered” his policies as effective. Now “Democrats need their own Trump — a wrecking ball who will challenge the party’s dogmas.” Liberal: How Dems Can Win Again “Democrats have lost the plot in the view of more and more nonwhite, especially nonwhite working-class , voters. How can they find it again?” asks The Liberal Patriot’s Ruy Teixeira . “Sever the party’s connection to unpopular and unworkable social policies and re-establish a focus on the material welfare of working-class voters” by moving to “to forcefully denounce said policies and unambiguously break from the forces in the party that are pushing these policies” on the border, crime, and social issues like gender surgeries for kids. As for those who insist “being a Democrat is inseparable from being a progressive as they define it ,” well: “It’s high time for Democrats to turn the tables” and throw the various identitarian factions “under the bus.” Senility watch: Biden’s Wobbly Final Months “As wars worsen” and Joe Biden enters his last months as president, the current moment is “especially perilous,” warns the Washington Examiner’s Bryon York . “In the last few days, Biden has removed restrictions on Ukraine’s use of the Army Tactical Missile System” and “Ukraine promptly fired U.S.-made missiles deep into Russian territory.” Putin has promised retribution. While these developments “would be alarming in any context,” they “come as the 82-year-old President Biden’s apparent cognitive decline continues.” Pushed out of the presidential race by Dem power-brokers, he “appeared to play almost no role in his final international conferences as president, the G20 summit in Brazil.” Biden’s “final, wobbly months as president” make for “a particularly dangerous period.” Eye on DC: A Restoration of Order “What we’re seeing with the swap of [Matt] Gaetz for [Pam] Bondi is actually a restoration of regular order,” argues National Review’s Jim Geraghty of the Trump attorney-general drama. For all the “doomsaying from Trump opponents” on how “congressional Republicans are a bunch of spineless lickspittles who would gladly use the U.S. Constitution as kindling just to see the warm glow reflected in the eyes of Trump,” plainly “there are some lines Senate Republicans aren’t willing to cross.” Trump can “be an effective president. He just needs to be surrounded by a good team, and the Republican Senate majority may need to periodically save Trump from his own worst instincts.” — Compiled by The Post Editorial Board
By MARY CLARE JALONICK and MATT BROWN WASHINGTON (AP) — Pete Hegseth, President-elect Donald Trump’s nominee to lead the Defense Department, said he had a “wonderful conversation” with Maine Sen. Susan Collins on Wednesday as he pushed to win enough votes for confirmation. He said he will not back down after allegations of excessive drinking and sexual misconduct. Related Articles National Politics | Donald Trump will ring the New York Stock Exchange bell. It’ll be a first for him National Politics | The Trump and Biden teams insist they’re working hand in glove on foreign crises National Politics | ‘You don’t know what’s next.’ International students scramble ahead of Trump inauguration National Politics | Trump is threatening to raise tariffs again. Here’s how China plans to fight back National Politics | Trump won’t be able to save the struggling US beef industry Collins said after the hourlong meeting that she questioned Hegseth about the allegations amid reports of drinking and the revelation that he made a settlement payment after being accused of a sexual assault that he denies. She said she had a “good, substantive” discussion with Hegseth and “covered a wide range of topics,” including sexual assault in the military, Ukraine and NATO. But she said she would wait until a hearing, and notably a background check, to make a decision. “I asked virtually every question under the sun,” Collins told reporters as she left her office after the meeting. “I pressed him both on his position on military issues as well as the allegations against him, so I don’t think there was anything that we did not cover.” The meeting with Collins was closely watched as she is seen as more likely than most of her Republican Senate colleagues to vote against some of Trump’s Cabinet picks. She and Alaska Sen. Lisa Murkowski, a fellow moderate Republican, did not shy from opposing Trump in his first term when they wanted to do so and sometimes supported President Joe Biden’s nominees for the judicial and executive branches. And Hegseth, an infantry combat veteran and former “Fox & Friends” weekend host, is working to gain as many votes as he can as some senators have expressed concerns about his personal history and lack of management experience. “I’m certainly not going to assume anything about where the senator stands,” Hegseth said as he left Collins’ office. “This is a process that we respect and appreciate. And we hope, in time, overall, when we get through that committee and to the floor that we can earn her support.” Hegseth met with Murkowski on Tuesday. He has also been meeting repeatedly with Iowa Sen. Joni Ernst, a military veteran who has said she is a survivor of sexual assault and has spent time in the Senate working on improving how attacks are reported and prosecuted within the ranks. On Monday, Ernst said after a meeting with him that he had committed to selecting a senior official to prioritize those goals. Republicans will have a 53-49 majority next year, meaning Trump cannot lose more than three votes on any of his nominees. It is so far unclear whether Hegseth will have enough support, but Trump has stepped up his pressure on senators in the last week. “Pete is a WINNER, and there is nothing that can be done to change that!!!” Trump posted on his social media platform last week.When fire threatened a California university, the school says it knew what to doNone
Telangana Cyber Sleuths Nab Scammer in Rs 8.14 Cr Trading Fraud
Grande, 31, also said her co-star was a “brilliant gift of a human being” while being interviewed by Gladiator star Paul Mescal for US news outlet Variety. Mescal told the singer and actor: “I’m watching you guys in the press tour. You’re obviously in love with each other.” To which she replied: “Insufferable. Yes. We’re horrible. It’s bad.” The 7 Rings singer plays Glinda, while her 37-year-old co-star plays Elphaba, in the film which is an adaption of the musical stage show of the same name and is set in The Land Of Oz before the events of The Wizard Of Oz. Their interviews for the film, which have seen the two being emotional towards one another and holding hands, have gone viral on social media. Speaking about Erivo, Grande said: “Cynthia is just an absolute brilliant gift of a human being. I think we tried to keep the pressure out of the room, obviously, as much as possible.” She also said she had not had any read throughs with her co-star before joining the cast. Grande said: “We never chemistry read together, it was three rounds for me, and I read with two different actresses. “I stayed for three and a half hours the final day, and I had cried so much. “We did Popular, Defying Gravity, (and) For Good (songs from the film), and I left my lashes on the mirror, because I left everything else in the room.” The film follows Elphaba, who is misunderstood because of her green skin, as she forges an unlikely friendship with Glinda, a student with a desire for popularity. Bullying of the green-skinned witch saw the movie, which also stars Peter Dinklage, Jeff Goldblum and Jonathan Bailey, given a PG rating by the British Board Of Film Classification (BBFC) for “discrimination”.Mangione family in Maryland: What we know
Juan Soto gets free luxury suite and up to 4 premium tickets for home games in $765M Mets dealBOONE, N.C. (AP) — Myles Tate led Appalachian State with 20 points and Dior Conners hit the game-winning 3-pointer with one second left as the Mountaineers defeated William & Mary 79-76 on Sunday. Tate had five rebounds and 10 assists for the Mountaineers (3-2). Conners went 5 of 9 from the field (5 for 8 from 3-point range) to add 15 points. CJ Huntley shot 6 of 9 from the field and 1 for 4 from the line to finish with 14 points. Noah Collier led the Tribe (3-5) in scoring, finishing with 19 points and eight rebounds. William & Mary also got 13 points from Malachi Ndur. Kyle Pulliam also had 12 points. Appalachian State went into the half leading William & Mary 42-30. Jamil Muttilib put up 12 points in the half. Tate led Appalachian State with 15 points in the second half. NEXT UP Appalachian State plays Wednesday against Sam Houston, and William & Mary visits Old Dominion on Monday. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
NEW YORK (AP) — U.S. stock indexes got back to climbing on Wednesday after the latest update on inflation appeared to clear the way for more help for the economy from the Federal Reserve . The S&P 500 rose 0.8% to break its first two-day losing streak in nearly a month and finished just short of its all-time high. Big Tech stocks led the way, which drove the Nasdaq composite up 1.8% to top the 20,000 level for the first time. The Dow Jones Industrial Average, meanwhile, lagged the market with a dip of 99 points, or 0.2%. Stocks got a boost as expectations built that Wednesday’s inflation data will allow the Fed to deliver another cut to interest rates at its meeting next week. Traders are betting on a nearly 99% probability of that, according to data from CME Group, up from 89% a day before. If they’re correct, it would be a third straight cut by the Fed after it began lowering rates in September from a two-decade high. It’s hoping to support a slowing job market after getting inflation nearly all the way down to its 2% target. Lower rates would give a boost to the economy and to prices for investments, but they could also provide more fuel for inflation. “The data have given the Fed the ‘all clear’ for next week, and today’s inflation data keep a January cut in active discussion,” according to Ellen Zentner, chief economic strategist for Morgan Stanley Wealth Management. Expectations for a series of cuts to rates by the Fed have been one of the main reasons the S&P 500 has set an all-time high 57 times this year , with the latest coming last week. The biggest boosts for the index on Wednesday came from Nvidia and other Big Tech stocks. Their massive growth has made them Wall Street’s biggest stars for years, though other kinds of stocks have recently been catching up somewhat amid hopes for the broader U.S. economy. Tesla jumped 5.9% to finish above $420 at $424.77. It’s a level that Elon Musk made famous in a 2018 tweet when he said he had secured funding to take Tesla private at $420 per share . Stitch Fix soared 44.3% after the company that sends clothes to your door reported a smaller loss for the latest quarter than analysts expected. It also gave financial forecasts for the current quarter that were better than expected, including for revenue. GE Vernova rallied 5% for one of the biggest gains in the S&P 500. The energy company that spun out of General Electric said it would pay a 25 cent dividend every three months, and it approved a plan to send up to another $6 billion to its shareholders by buying back its own stock. On the losing end of Wall Street, Dave & Buster’s Entertainment tumbled 20.1% after reporting a worse loss for the latest quarter than expected. It also said CEO Chris Morris has resigned, and the board has been working with an executive-search firm for the last few months to find its next permanent leader. Albertsons fell 1.5% after filing a lawsuit against Kroger, saying it didn’t do enough for their proposed $24.6 billion merger agreement to win regulatory clearance. Albertsons said it’s seeking billions of dollars in damages from Kroger, whose stock rose 1%. A day earlier, judges in separate cases in Oregon and Washington nixed the supermarket giants’ merger. The grocers contended a combination could have helped them compete with big retailers like Walmart, Costco and Amazon, but critics said it would hurt competition. After terminating the merger agreement with Kroger, Albertsons said it plans to boost its dividend 25% and increased the size of its program to buy back its own stock. Macy’s slipped 0.8% after cutting some of its financial forecasts for the full year of 2024, including for how much profit it expects to make off each $1 of revenue. All told, the S&P 500 rose 49.28 points to 6,084.19. The Dow dipped 99.27 to 44,148.56, and the Nasdaq composite rallied 347.65 to 20,034.89. In the bond market, the yield on the 10-year Treasury rose to 4.27% from 4.23% late Tuesday. The two-year Treasury yield, which more closely tracks expectations for the Fed, edged up to 4.15% from 4.14%. In stock markets abroad, indexes rose across much of Europe and Asia. Hong Kong’s Hang Seng was an outlier and slipped 0.8% as Chinese leaders convened an annual planning meeting in Beijing that is expected to set economic policies and growth targets for the coming year. South Korea’s Kospi rose 1%, up for a second straight day as it climbs back following last week’s political turmoil where its president briefly declared martial law. AP Writers Matt Ott and Zimo Zhong contributed.
Nutter and Georgia State take down Tulsa 74-71
Canara Bank: What should investors doNoneCHICAGO, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the recipients of the 2024 FSR Cardiac Sarcoidosis Grant, providing $200,000 in funding to advance groundbreaking research aimed at improving the diagnosis, management, and treatment of cardiac sarcoidosis and doubling FSR's investment from 2023. FSR has awarded two grants, each in the amount of $100,000, to Dr. Eliot Peyster, MD, MSc, Assistant Professor of Medicine at the University of Pennsylvania, and Dr. Ravi Karra, MD, MHS, Associate Professor of Medicine and Pathology at Duke University. These grants support innovative projects designed to improve diagnostic accuracy and clinical care for cardiac sarcoidosis patients. Dr. Peyster's research project, Establishing a True Gold Standard for Cardiac Sarcoidosis Diagnosis with Quantitative Multi-marker Immunofluorescence , applies advanced spatial biology techniques to create a new diagnostic gold standard for cardiac sarcoidosis, leveraging quantitative multi-marker immunofluorescence. His expertise spans cardiovascular diseases, heart failure, and translational research, with a focus on adapting cutting-edge technologies to improve patient care. "This generous award from the FSR will enable us to test a novel, modern, and very promising new approach to diagnosing cardiac sarcoidosis,” says Dr. Peyster. "The work we will perform as part of this award has the potential to be practice-changing and will hopefully lead to earlier disease detection and better outcomes for patients.” Dr. Karra's research project, Repurposing 99mTc-Tilmanocept Imaging for Cardiac Sarcoidosis , focuses on adapting macrophage-specific imaging agents to improve cardiac sarcoidosis diagnosis and monitoring. His translational program at Duke University combines developmental biology and epidemiology to advance early-phase clinical trials and improve care for heart failure patients. "With generous support from the Foundation for Sarcoidosis Research, we are excited to test whether an imaging agent specific to macrophages can be used to better diagnose and follow cardiac sarcoidosis,” says Dr. Karra. "This work is part of a bench-to-bedside approach from my lab and has the potential to address a significant, unmet need in the field of sarcoidosis.” "We are thrilled to support these extraordinary projects through FSR's Cardiac Sarcoidosis Grant," says Mary McGowan, FSR's CEO. "The insights gained from this research have the potential to revolutionize the diagnosis, outcome evaluation, and treatment strategies not only for individuals with cardiac sarcoidosis but also for a wide range of other inflammatory diseases." FSR is dedicated to accelerating sarcoidosis research through its fellowships, pilot and cardiac grants, and other disease-specific initiatives. To date, FSR has provided more than $7 million in funding to support sarcoidosis research worldwide. To learn more about FSR's funding opportunities, visit https://www.stopsarcoidosis.org/fsr-grants/ . About Sarcoidosis Sarcoidosis is a rare inflammatory disease characterized by granulomas-tiny clumps of inflammatory cells-that can form in one or more organs. Despite advances in research, sarcoidosis remains challenging to diagnose, with limited treatment options and no known cure. Approximately 175,000 people live with sarcoidosis in the United States. About the Foundation for Sarcoidosis Research The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and improving care for those living with the disease through research, education, and support. For more information about FSR and its community programs, visit: www.stopsarcoidosis.org . Media contact: Cathi Davis Director of Communications and Marketing 312-341-0500 A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e117b7a-964e-442d-b5ed-d7fff74c93b9By MARY CLARE JALONICK and MATT BROWN WASHINGTON (AP) — Pete Hegseth, President-elect Donald Trump’s nominee to lead the Defense Department, said he had a “wonderful conversation” with Maine Sen. Susan Collins on Wednesday as he pushed to win enough votes for confirmation. He said he will not back down after allegations of excessive drinking and sexual misconduct. Related Articles National Politics | Donald Trump will ring the New York Stock Exchange bell. It’ll be a first for him National Politics | The Trump and Biden teams insist they’re working hand in glove on foreign crises National Politics | ‘You don’t know what’s next.’ International students scramble ahead of Trump inauguration National Politics | Trump is threatening to raise tariffs again. Here’s how China plans to fight back National Politics | Trump won’t be able to save the struggling US beef industry Collins said after the hourlong meeting that she questioned Hegseth about the allegations amid reports of drinking and the revelation that he made a settlement payment after being accused of a sexual assault that he denies. She said she had a “good, substantive” discussion with Hegseth and “covered a wide range of topics,” including sexual assault in the military, Ukraine and NATO. But she said she would wait until a hearing, and notably a background check, to make a decision. “I asked virtually every question under the sun,” Collins told reporters as she left her office after the meeting. “I pressed him both on his position on military issues as well as the allegations against him, so I don’t think there was anything that we did not cover.” The meeting with Collins was closely watched as she is seen as more likely than most of her Republican Senate colleagues to vote against some of Trump’s Cabinet picks. She and Alaska Sen. Lisa Murkowski, a fellow moderate Republican, did not shy from opposing Trump in his first term when they wanted to do so and sometimes supported President Joe Biden’s nominees for the judicial and executive branches. And Hegseth, an infantry combat veteran and former “Fox & Friends” weekend host, is working to gain as many votes as he can as some senators have expressed concerns about his personal history and lack of management experience. “I’m certainly not going to assume anything about where the senator stands,” Hegseth said as he left Collins’ office. “This is a process that we respect and appreciate. And we hope, in time, overall, when we get through that committee and to the floor that we can earn her support.” Hegseth met with Murkowski on Tuesday. He has also been meeting repeatedly with Iowa Sen. Joni Ernst, a military veteran who has said she is a survivor of sexual assault and has spent time in the Senate working on improving how attacks are reported and prosecuted within the ranks. On Monday, Ernst said after a meeting with him that he had committed to selecting a senior official to prioritize those goals. Republicans will have a 53-49 majority next year, meaning Trump cannot lose more than three votes on any of his nominees. It is so far unclear whether Hegseth will have enough support, but Trump has stepped up his pressure on senators in the last week. “Pete is a WINNER, and there is nothing that can be done to change that!!!” Trump posted on his social media platform last week.
Friendly reminder |
The authenticity of this information has not been verified by this website and is for your reference only. Please do not reprint without permission. If authorized by this website, it should be used within the scope of authorization and marked with "Source: this website". |
Special attention |
Some articles on this website are reprinted from other media. The purpose of reprinting is to convey more industry information, which does not mean that this website agrees with their views and is responsible for their authenticity. Those who make comments on this website forum are responsible for their own content. This website has the right to reprint or quote on the website. The comments on the forum do not represent the views of this website. If you need to use the information provided by this website, please contact the original author. The copyright belongs to the original author. If you need to contact this website regarding copyright, please do so within 15 days. |